PlainRecalls
FDA Drug Moderate Class II Terminated

HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2012-1

Reported: August 9, 2023 Initiated: July 17, 2023 #D-1060-2023

Product Description

HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2012-1

Reason for Recall

Lack of assurance of sterility: Lack of validation data for sanitization cycles

Details

Units Affected
5,259 syringes
Distribution
Nationwide in the USA
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
HYDROmorphone in 0.9% sodium chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2012-1. Recalled by Central Admixture Pharmacy Services Inc. Units affected: 5,259 syringes.
Why was this product recalled?
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Which agency issued this recall?
This recall was issued by the FDA Drug on August 9, 2023. Severity: Moderate. Recall number: D-1060-2023.